Pharmaceuticals
Biotechnology
Oncology
Innovation
Discovery
Development
Commercialization
United
M&A Advisory
Lazard
Full Credential Description
OSI Pharmaceuticals. Japan, United States. Announced Date 16/05/2010. Closed Date 09/06/2010. Deal value: $4000m. Astellas Pharma to Acquire OSI Pharmaceuticals. Industry: OSI Pharmaceuticals is a biotechnology company focused on the discovery, development, and commercialization of innovative pharmaceutical products for oncology.